{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:47:26Z","timestamp":1772894846659,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.clim.2006.03.003","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T13:21:51Z","timestamp":1146662511000},"page":"129-137","source":"Crossref","is-referenced-by-count":19,"title":["Modulation of the systemic inflammatory response by recombinant human interleukin-11: A prospective randomized placebo controlled clinical study in patients with hematological malignancy"],"prefix":"10.1016","volume":"120","author":[{"given":"Michael","family":"Ellis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Hedstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorgen","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuad V.","family":"Shammas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basel K.","family":"al-Ramadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2006.03.003_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(03)12322-7","article-title":"Recombinant interleukin 11 and bacterial infection in patients with haematological malignancy undergoing chemotherapy: a double-blind placebo-controlled randomized trial","volume":"361","author":"Ellis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2006.03.003_bib2","first-page":"1503","article-title":"Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease","volume":"78","author":"Peterson","year":"1998","journal-title":"Lab. Invest."},{"key":"10.1016\/j.clim.2006.03.003_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI3132","article-title":"Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"102","author":"Hill","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2006.03.003_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2006.03.003_bib5","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","article-title":"Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993","volume":"106","author":"Rowe","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2006.03.003_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1200\/JCO.2005.06.090","article-title":"Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study","volume":"23","author":"Farag","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clim.2006.03.003_bib7","first-page":"864","article-title":"American college of chest physicians\/society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"20","author":"Anonymous","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.clim.2006.03.003_bib8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2006.03.003_bib9","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"SCCM\/ESICM\/ACCP\/ATS\/SIS, 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.clim.2006.03.003_bib10","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1002\/j.1460-2075.1994.tb06802.x","article-title":"Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction","volume":"13","author":"Hilton","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.clim.2006.03.003_bib11","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.157.8.3627","article-title":"Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production","volume":"157","author":"Trepicchio","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.03.003_bib12","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1182\/blood.V97.9.2758","article-title":"Interleukin-11 induces Th2 polarization of human CD4(+) T cells","volume":"97","author":"Curti","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clim.2006.03.003_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.bmt.1703394","article-title":"A phase I\/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation","volume":"29","author":"Antin","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.clim.2006.03.003_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/ar309","article-title":"Results of a phase-I\/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis","volume":"3","author":"Moreland","year":"2001","journal-title":"Arthritis Res."},{"key":"10.1016\/j.clim.2006.03.003_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2036.2002.01179.x","article-title":"Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease","volume":"16","author":"Sands","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.clim.2006.03.003_bib16","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.167.4.1511","article-title":"A human inhibitor of tumor necrosis factor alpha","volume":"167","author":"Seckinger","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.03.003_bib17","doi-asserted-by":"crossref","first-page":"11974","DOI":"10.1016\/S0021-9258(18)80162-4","article-title":"A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity","volume":"264","author":"Engelmann","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2006.03.003_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1359-6101(03)00022-4","article-title":"Biological functions of tumor necrosis factor cytokines and their receptors","volume":"14","author":"Pfeffer","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.clim.2006.03.003_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.clim.2006.03.003_bib20","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4049\/jimmunol.157.5.2155","article-title":"TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense","volume":"157","author":"Steinshamn","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.03.003_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/IAI.67.2.595-601.1999","article-title":"Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections","volume":"67","author":"O'Brien","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2006.03.003_bib22","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/364798a0","article-title":"Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes","volume":"364","author":"Rothe","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.clim.2006.03.003_bib23","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.160.2.943","article-title":"TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation","volume":"160","author":"Peschon","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.03.003_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-065X.1999.tb01315.x","article-title":"On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease","volume":"169","author":"Kollias","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2006.03.003_bib25","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.158.8.3869","article-title":"Constitutive shedding of both p55 and p75 murine TNF receptors in vivo","volume":"158","author":"Pinckard","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.03.003_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/1043-4666(90)90048-X","article-title":"Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans","volume":"2","author":"Lantz","year":"1990","journal-title":"Cytokine"},{"key":"10.1016\/j.clim.2006.03.003_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01489489","article-title":"Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-alpha antibody","volume":"15","author":"Jansen","year":"1995","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2006.03.003_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55\u00a0kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.clim.2006.03.003_bib29","first-page":"L861","article-title":"Interleukin-11 attenuates pulmonary inflammation and vasomotor dysfunction in endotoxin-induced lung injury","volume":"277","author":"Sheridan","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.clim.2006.03.003_bib30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.172.2.599","article-title":"Shedding of tumor necrosis factor receptors by activated human neutrophils","volume":"172","author":"Porteu","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.03.003_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V83.1.113.113","article-title":"Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55","volume":"83","author":"Tilg","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.clim.2006.03.003_bib32","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.4049\/jimmunol.152.6.3189","article-title":"Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro","volume":"152","author":"Tilg","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.03.003_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00001432-200106000-00007","article-title":"The role of C-reactive protein in the resolution of bacterial infection","volume":"14","author":"Du Clos","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.clim.2006.03.003_bib34","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1084\/jem.178.5.1629","article-title":"Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells","volume":"178","author":"Tilg","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.03.003_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1084\/jem.20040435","article-title":"Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases","volume":"200","author":"Xanthoulea","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.03.003_bib36","first-page":"373","article-title":"The gut mucosa in bone marrow transplantation","volume":"5","author":"Fegan","year":"1990","journal-title":"Bone Marrow Transplant."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606000830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606000830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T09:03:22Z","timestamp":1683450202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661606000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1521661606000830"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2006.03.003","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}